Fa yi xue za zhi

Recent Advances in Understanding Mescaline and Similar Compounds

Psychedelic Science Weekly Brief ↗PubMed ↗DOI ↗

Updated

Abstract

Mescaline and its analogues are increasingly abused psychoactive substances.

  • Recent years have seen a gradual increase in the abuse of mescaline and its analogues.
  • The review covers basic information about mescaline and its analogues.
  • Pharmacological and toxicological properties of these substances are discussed.
  • Various detection methods for mescaline and its analogues are presented.
  • Insights are provided for future research and forensic examination related to these substances.

Simplified

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free

Recent issues from the psychedelic science brief

issue #49
Psilocybin stays active in neurons long after it leaves the bloodstream — here's what that means
2 days ago7 studies
issue #48
Psychedelics during adolescence reshaped adult social behavior in rats — here's the circuit
1 week ago7 studies
issue #47
Psilocybin rewired prefrontal circuits in mice — but only for one specific type of cognitive failure
2 weeks ago7 studies
issue #46
Psilocybin cut two specific brain chemicals in depressed patients — here's what that means
3 weeks ago7 studies
issue #44
Psilocybin rewires brain feedback circuits for weeks after a single dose, new evidence shows
4 weeks ago7 studies
issue #43
A pill form of ketamine cut dissociation to near-zero vs. nasal spray's 29.6-point spike — but missed its main antidepressant target
5 weeks ago7 studies
issue #42
At-home ketamine injections cut depression scores by more than half in 3,870 patients
6 weeks ago8 studies
issue #41
Psychedelics disrupt brain signal flow in both humans and mice across LSD, psilocybin, and MDMA
7 weeks ago7 studies
issue #40
Inhaled 5-MeO-DMT cut postpartum depression scores by 35 points
8 weeks ago7 studies
issue #39
Psilocybin's antidepressant effects lasted 12 months in 126 treatment-resistant patients
9 weeks ago7 studies
explore the archive
See more issues from the psychedelic science brief